Literature DB >> 8642677

Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution.

J M Burrows1, S R Burrows, L M Poulsen, T B Sculley, D J Moss, R Khanna.   

Abstract

Cytotoxic T lymphocytes (CTLs) which recognize viral antigens in association with human leukocyte antigens (HLAs) play an important role in controlling persistent virus infections. These viruses use several mechanisms to evade the immune response, including mutations that affect either T-cell receptor recognition or binding of viral epitopes to the HLA. It has recently been proposed that the distribution of HLA frequencies and the specific CTL response may influence the long-term evolution of Epstein-Barr virus (EBV) by selecting variants which lack immunodominant CTL epitopes. To test this hypothesis, we have studied EBV isolates from two genetically distinct Papua New Guinea (PNG) populations, residing in coastal and highland regions, for polymorphism within seven viral CTL epitope sequences restricted through several class I HLAs. Surprisingly, all EBV isolates analyzed displayed identical amino acid substitutions within HLA A11-, B35- and B8-restricted CTL epitope sequences which completely abrogated CTL recognition and binding of synthetic peptides to HLA molecules. Furthermore, these substitutions revealed no correlation with the contemporary distribution of HLAs in the different PNG populations, which argues for a minimal influence of immune pressure. The sequence homology between EBV isolates from coastal and highland PNG suggests that the virus may have had a single origin and, more importantly, that these isolates are genetically distinct from those present in a Caucasian population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642677      PMCID: PMC190093     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus.

Authors:  T B Sculley; A Apolloni; R Stumm; D J Moss; N Mueller-Lantczh; I S Misko; D A Cooper
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

2.  Immunogenetic studies of two recently contacted populations from Papua New Guinea.

Authors:  K Bhatia; C Jenkins; M Prasad; G Koki; J Lombange
Journal:  Hum Biol       Date:  1989-02       Impact factor: 0.553

3.  HLA studies of Highland and Coastal New Guineans.

Authors:  G Crane; K Bhatia; M Honeyman; T Doran; N Messel; G Hakos; D Tarlinton; D B Amos; H Bashir
Journal:  Hum Immunol       Date:  1985-04       Impact factor: 2.850

4.  Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft.

Authors:  D H Crawford; J A Thomas; G Janossy; P Sweny; O N Fernando; J F Moorhead; J H Thompson
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321

5.  Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.

Authors:  D J Moss; I S Misko; S R Burrows; K Burman; R McCarthy; T B Sculley
Journal:  Nature       Date:  1988-02-25       Impact factor: 49.962

6.  Malaria and hereditary ovalocytosis.

Authors:  S Serjeantson; K Bryson; D Amato; D Babona
Journal:  Hum Genet       Date:  1977-06-30       Impact factor: 4.132

7.  Early acquisition of cytomegalovirus and Epstein-Barr virus antibody in several isolated Melanesian populations.

Authors:  D J Lang; R M Garruto; D C Gajdusek
Journal:  Am J Epidemiol       Date:  1977-05       Impact factor: 4.897

8.  Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo.

Authors:  J A Byrne; M B Oldstone
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

Review 9.  Immune regulation in Epstein-Barr virus-associated diseases.

Authors:  R Khanna; S R Burrows; D J Moss
Journal:  Microbiol Rev       Date:  1995-09

10.  A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.

Authors:  H Tsubota; C I Lord; D I Watkins; C Morimoto; N L Letvin
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  24 in total

1.  Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Authors:  J T Voeten; T M Bestebroer; N J Nieuwkoop; R A Fouchier; A D Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  The immunology of Epstein-Barr virus infection.

Authors:  D J Moss; S R Burrows; S L Silins; I Misko; R Khanna
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

3.  Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes.

Authors:  R S Midgley; A I Bell; D J McGeoch; A B Rickinson
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Specific mutation of a gammaherpesvirus-expressed antigen in response to CD8 T cell selection in vivo.

Authors:  Joy Loh; Daniel L Popkin; Lindsay Droit; Douglas C Braaten; Guoyan Zhao; Xin Zhang; Punit Vachharajani; Nancy Myers; Ted H Hansen; Herbert W Virgin
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

5.  Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation.

Authors:  Daniëlle Horst; Scott R Burrows; Derek Gatherer; Bonnie van Wilgenburg; Melissa J Bell; Ingrid G J Boer; Maaike E Ressing; Emmanuel J H J Wiertz
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

6.  Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift.

Authors:  R Khanna; R W Slade; L Poulsen; D J Moss; S R Burrows; J Nicholls; J M Burrows
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Cytotoxic T-lymphocyte clones specific for an immunodominant epitope display discerning antagonistic response to naturally occurring Epstein-Barr virus variants.

Authors:  R Khanna; S R Burrows; S L Silins; D J Moss; L M Poulsen; J M Burrows
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

8.  Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences.

Authors:  J M Burrows; R Khanna; T B Sculley; M P Alpers; D J Moss; S R Burrows
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

9.  HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.

Authors:  R S Midgley; A I Bell; Q Y Yao; D Croom-Carter; A D Hislop; B M Whitney; A T C Chan; P J Johnson; A B Rickinson
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 10.  The human leukocyte antigen class I genes in nasopharyngeal carcinoma risk.

Authors:  Elham Hassen; Ghandri Nahla; Noureddine Bouaouina; Lotfi Chouchane
Journal:  Mol Biol Rep       Date:  2009-05-17       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.